Literature DB >> 9349732

Aortic calcification produced by vitamin D3 plus nicotine.

N Niederhoffer1, Y V Bobryshev, I Lartaud-Idjouadiene, P Giummelly, J Atkinson.   

Abstract

Calcification of the elastic arteries of the young rat by treatment with vitamin D and nicotine (VDN) has been proposed as an animal model of arterial calcification associated with age and age-related vascular pathology in man. The calcium-binding protein, S-100, which is found in human atherosclerotic lesions was associated with medial calcification of the aorta in VDN rats, especially in cases of severe calcification. Calcification (total calcium content: 366 +/- 87, n = 12 in VDN vs. 24 +/- 2 micromol g(-1) aortic dry weight in controls, n = 13) involved elastocalcinosis leading to elastolysis as revealed by a fall in the amount of desmosine and isodesmosine in the aortic wall (266 +/- 17 and 254 +/- 15 in VDN vs. 655 +/- 56 and 588 +/- 30 microg g(-1) aortic dry weight in controls). The decrease in elastin was associated with an increase in the stiffness of the aortic wall (elastic modulus: 15.1 +/- 1.8 in VDN vs. 6.7 +/- 0.5 10(6) dyn cm(-2) in controls), an increase in end-systolic stress (central systolic aortic pressure: 152 +/- 6 in VDN vs. 136 +/- 2 mm Hg in controls) (at a normotensive mean pressure level) and left ventricular hypertrophy (heart weight/body weight 2.51 +/- 0.10 in VDN vs. 2.24 +/- 0.07 g kg(-1) in controls). In conclusion, the mechanisms and consequences of aortic calcification in VDN show several similarities with calcification occurring in human athero- and arteriosclerosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9349732     DOI: 10.1159/000159247

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  28 in total

Review 1.  Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.

Authors:  Kamyar Kalantar-Zadeh; Anuja Shah; Uyen Duong; Rulin C Hechter; Ramanath Dukkipati; Csaba P Kovesdy
Journal:  Kidney Int Suppl       Date:  2010-08       Impact factor: 10.545

Review 2.  The dualistic role of vitamin D in vascular calcifications.

Authors:  M Shawkat Razzaque
Journal:  Kidney Int       Date:  2010-10-20       Impact factor: 10.612

3.  Reversible vascular calcifications associated with hypervitaminosis D.

Authors:  Massimo Cirillo; Giancarlo Bilancio; Chiara Cirillo
Journal:  J Nephrol       Date:  2015-08-30       Impact factor: 3.902

4.  A rat model of diabetic artery calcification.

Authors:  X Ren; Qin Wei; H Shao; Z Sun; N Liu
Journal:  J Endocrinol Invest       Date:  2011-07-12       Impact factor: 4.256

5.  C-type natriuretic peptide inhibiting vascular calcification might involve decreasing bone morphogenic protein 2 and osteopontin levels.

Authors:  Jing-Jing Chen; Jing Zhang; Yan Cai; Ye-Bo Zhou; Ge-Bo Wen; Chao-Shu Tang; Yong-Fen Qi; Zhi-Sheng Jiang
Journal:  Mol Cell Biochem       Date:  2014-04-08       Impact factor: 3.396

6.  Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study.

Authors:  Mishaela R Rubin; Tanja Rundek; Donald J McMahon; Hye-Seung Lee; Ralph L Sacco; Shonni J Silverberg
Journal:  Atherosclerosis       Date:  2006-10-09       Impact factor: 5.162

Review 7.  Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window.

Authors:  Uwe Querfeld; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-06-22       Impact factor: 3.714

8.  Flavocoxid Ameliorates Aortic Calcification Induced by Hypervitaminosis D3 and Nicotine in Rats Via Targeting TNF-α, IL-1β, iNOS, and Osteogenic Runx2.

Authors:  Ahmed E Amer; George S G Shehatou; Hassan A El-Kashef; Manar A Nader; Ahmed R El-Sheakh
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-26       Impact factor: 3.727

9.  Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads.

Authors:  Terence M Doherty; Kamlesh Asotra; Lorraine A Fitzpatrick; Jian-Hua Qiao; Douglas J Wilkin; Robert C Detrano; Colin R Dunstan; Prediman K Shah; Tripathi B Rajavashisth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

Review 10.  Potential for vitamin D receptor agonists in the treatment of cardiovascular disease.

Authors:  J R Wu-Wong
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.